J. R. Infante
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine
- Computational Theory and Mathematics top 5%
- Immunology
- Co-authors
- Howard A. BurrisRichard KeffordG. S. FalchookGeorgina V. LongPeter F. LebowitzM.J. MillwardMichael P. BrownSuzanne F. Jones
- Topics
- Cancer Treatment and Pharmacology (15 papers)Lung Cancer Treatments and Mutations (14 papers)PI3K/AKT/mTOR signaling in cancer (10 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
J. R. Infante
67 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 862
- Oncology 630
- Pulmonary and Respiratory Medicine 146
- Computational Theory and Mathematics 135
- Immunology 114
Countries citing papers authored by J. R. Infante
This map shows the geographic impact of J. R. Infante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. R. Infante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. R. Infante more than expected).
Fields of papers citing papers by J. R. Infante
This network shows the impact of papers produced by J. R. Infante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. R. Infante. The network helps show where J. R. Infante may publish in the future.
Co-authorship network of co-authors of J. R. Infante
This figure shows the co-authorship network connecting the top 25 collaborators of J. R. Infante. A scholar is included among the top collaborators of J. R. Infante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. R. Infante. J. R. Infante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 14 | |
| 5 | Safety of avelumab (MSB0010718C), an anti-PD-L1 antibody : updated analysis from the phase Ib JAVELIN solid tumor trial | 1 |
| 6 | 36 | |
| 7 | 4 | |
| 8 | 4 | |
| 9 | 11 | |
| 10 | 19 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 7 | |
| 14 | 44 | |
| 15 | 12 | |
| 16 | 7 | |
| 17 | 18 | |
| 18 | 3 | |
| 19 | 19 | |
| 20 | 5 |
About J. R. Infante
J. R. Infante is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Lung Cancer Treatments and Mutations (14 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). The work is most often cited by research in Oncology (630 citations), Molecular Biology (862 citations) and Computational Theory and Mathematics (135 citations). J. R. Infante has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Howard A. Burris, Richard Kefford, G. S. Falchook, Georgina V. Long, Peter F. Lebowitz, M.J. Millward, Michael P. Brown, Suzanne F. Jones, Hendrik‐Tobias Arkenau and H. A. Burris. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.